arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Marsh

MRSH Finance Specialty Insurers
$185.74
▲ +0.0% Today
as of Sep 4, 16:51 ET
Last 30 days +1.33% Jul 27 → Sep 04
$182.17 $186.31 $190.45 $194.59 $198.73 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$186.54
High
$187.69
Low
$185.42
Volume
$1M
Avg Vol
$3M
Mkt Cap
$89.9B
P/E (TTM)
29.64
Beta
—
52w High
$207.83
52w Low
$156.60
Div Yield
—
Shares Out
$478M

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 3 ● 22 ▼ 0
Sep 3 · 21:25 MT Newswires neutral
Marsh & Mclennan Companies Insider Sold Shares Worth $3,139,823, According to a Recent SEC Filing
Sep 3 · 14:34 Zacks neutral
How Can Healthcare Inflation Fuel Growth for MRSH, UNH & CNC?
Sep 2 · 19:05 PRODUCT Simply Wall St. bullish
Marsh & McLennan Companies (MRSH) Launches Cyber Protect And Marsh Re, Is The Stock Still Undervalued?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$157
$208
57% of range
Avg surprise (last 2)
+2.8%
Avg reaction (last 1)
-0.4%
0% positive
Latest IV / EM
23%
EM ±3.6% · $185 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.47$1.81$2.15$2.48$2.82 Actual $2.47Actual $2.07Actual $1.47Actual $2.82Actual $2.27Actual $1.51Actual $2.79Actual $2.72Est $2.66Actual $1.85Est $1.79Actual $2.36Actual $2.63 MarJunSepMarJunSepMarJun/2025Sep/2025MarJun
Revenue vs Net Income Revenue Net income
$0$2.0B$4.0B$6.0B$8.0B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $2.63 — — — — financials
Tue Mar 31, 2026Mar 2026 $2.36 — — — — financials
Thu Oct 16, 2025Sep/2025 $1.85 $1.79 +3.4% — — earnings
Thu Jul 17, 2025Jun/2025 $2.72 $2.66 +2.3% — -0.4% earnings
Mon Mar 31, 2025Mar 2025 $2.79 — — — — financials
Mon Sep 30, 2024Sep 2024 $1.51 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.27 — — — — financials
Sun Mar 31, 2024Mar 2024 $2.82 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.47 — — — — financials
Fri Jun 30, 2023Jun 2023 $2.07 — — — — financials
Fri Mar 31, 2023Mar 2023 $2.47 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$7.40B$7.60B—$6.35B$6.97B$7.06B—$5.70B
Cost of revenue————————
Gross profit————————
Operating income$1.90B$1.75B—$1.17B$1.83B$2.00B—$1.11B
Net income$1.27B$1.15B—$747M$1.21B$1.38B—$747M
EPS (diluted)$2.63$2.36—$1.51$2.45$2.79—$1.51

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$1.70B$1.61B$2.69B$2.51B$1.68B$1.60B$2.40B$1.80B
Inventory————————
Total current assets$24.33B$23.24B$23.20B$23.70B$23.33B$22.46B$22.12B$22.29B
Total assets$59.68B$58.55B$58.71B$58.78B$58.55B$57.02B$56.48B$49.86B
Long-term debt$18.89B$18.90B$18.32B$18.32B$18.96B$18.86B$19.43B$12.33B
Total liabilities————————
Total equity$15.43B$14.81B$15.31B$15.36B$15.98B$14.27B—$13.88B

Implied volatility — last 90 days

19%26%32%38%45% Jun 07 — IV 33% · EM ±4.6%Jun 08 — IV 30% · EM ±4.0%Jun 09 — IV 30% · EM ±3.7%Jun 10 — IV 31% · EM ±3.7%Jun 11 — IV 27% · EM ±3.0%Jun 12 — IV 27% · EM ±2.7%Jun 15 — IV 35% · EM ±2.5%Jun 16 — IV 31% · EM ±1.8%Jun 17 — IV 41% · EM ±1.7%Jun 19 — IV 28% · EM ±6.3%Jun 22 — IV 29% · EM ±6.1%Jun 23 — IV 27% · EM ±5.5%Jun 24 — IV 25% · EM ±5.0%Jun 25 — IV 28% · EM ±5.5%Jun 26 — IV 22% · EM ±4.3%Jun 29 — IV 25% · EM ±4.4%Jun 30 — IV 26% · EM ±4.4%Jul 01 — IV 25% · EM ±4.1%Jul 02 — IV 22% · EM ±3.6%Jul 03 — IV 23% · EM ±3.6%Jul 06 — IV 27% · EM ±3.7%Jul 07 — IV 27% · EM ±3.5%Jul 08 — IV 28% · EM ±3.6%Jul 09 — IV 30% · EM ±3.5%Jul 10 — IV 23% · EM ±2.6%Jul 13 — IV 28% · EM ±2.3%Jul 14 — IV 31% · EM ±2.3%Jul 15 — IV 30% · EM ±1.7%Jul 16 — IV 45% · EM ±1.9%Jul 20 — IV 33% · EM ±7.8%Jul 21 — IV 24% · EM ±5.5%Jul 22 — IV 25% · EM ±5.7%Jul 23 — IV 23% · EM ±5.1%Jul 24 — IV 23% · EM ±5.0%Jul 27 — IV 25% · EM ±5.2%Jul 28 — IV 23% · EM ±4.8%Jul 29 — IV 22% · EM ±4.5%Jul 30 — IV 25% · EM ±4.9%Jul 31 — IV 27% · EM ±5.2%Aug 03 — IV 26% · EM ±4.7%Aug 04 — IV 23% · EM ±4.0%Aug 05 — IV 24% · EM ±4.0%Aug 06 — IV 26% · EM ±4.2%Aug 07 — IV 24% · EM ±3.7%Aug 10 — IV 20% · EM ±2.8%Aug 11 — IV 24% · EM ±3.2%Aug 12 — IV 25% · EM ±3.1%Aug 13 — IV 27% · EM ±3.2%Aug 14 — IV 21% · EM ±2.3%Aug 17 — IV 22% · EM ±1.8%Aug 18 — IV 29% · EM ±2.1%Aug 19 — IV 28% · EM ±1.6%Aug 20 — IV 42% · EM ±1.7%Aug 24 — IV 21% · EM ±4.4%Aug 25 — IV 21% · EM ±4.3%Aug 26 — IV 23% · EM ±4.6%Aug 27 — IV 28% · EM ±5.5%Aug 28 — IV 22% · EM ±4.2%Aug 31 — IV 23% · EM ±4.1%Sep 01 — IV 25% · EM ±4.3%Sep 02 — IV 25% · EM ±4.2%Sep 03 — IV 20% · EM ±3.2%Sep 04 — IV 23% · EM ±3.6%

Sector peers

JPM
J P Morgan Chase & Co
$962.4B $358.500.0%
BAC
Bank of America Corporation
$440.8B $62.68-0.0%
HSBC
HSBC Holdings plc
$349.6B $107.30+0.2%
MS
Morgan Stanley
$341.0B $218.00+0.1%
GS
The Goldman Sachs Group, Inc.
$302.2B $1,038.61+0.0%
RY
Royal Bank Of Canada
$292.3B $210.75+0.1%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in